Theranostics · 2019 · 118 citations · 33 references
PharmacyOncologyPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryCancer Drug DeliveryCancer NanomedicineNanomedicineNanoparticle Delivery SystemsTargeted Cancer TherapyTheranostic NanoparticlesIron Oxide NanoparticlesMagnetic Nanoparticle Drug DeliveryMagnetic NanoparticlesMagnetic Oxide NanoparticlesNanoparticle DeliveryNanoparticle Imaging AgentsNanoparticlesTheranostic Nanomaterials
The inability to completely excise peritoneal metastatic tumors by debulking surgery as well as resistance to chemotherapy are the major clinical challenges for ovarian cancer treatment. This targeted cancer therapy has the potential for the development of effective treatment for metastatic ovarian cancer.
33
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
José Baselga, Javier Cortés, Sung‐Bae Kim et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text
Medicine, Oncology, Pharmacology +12
Michael A. Bookman, Kathleen M. Darcy, Daniel L. Clarke‐Pearson et al. · Journal of Clinical Oncology · 2003 · 613 citations
Medicine, Gynecology, Oncology +17